Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 131

Similar articles for PubMed (Select 20664904)

1.

Association study between polymorphims in GAS6-TAM genes and carotid atherosclerosis.

Hurtado B, Abasolo N, Muñoz X, García N, Benavente Y, Rubio F, García de Frutos P, Krupinski J, Sala N.

Thromb Haemost. 2010 Sep;104(3):592-8. doi: 10.1160/TH09-11-0787. Epub 2010 Jul 20.

PMID:
20664904
2.

Expression of the vitamin K-dependent proteins GAS6 and protein S and the TAM receptor tyrosine kinases in human atherosclerotic carotid plaques.

Hurtado B, Muñoz X, Recarte-Pelz P, García N, Luque A, Krupinski J, Sala N, García de Frutos P.

Thromb Haemost. 2011 May;105(5):873-82. doi: 10.1160/TH10-10-0630. Epub 2011 Mar 8.

PMID:
21384080
3.

Association of specific haplotypes of GAS6 gene with stroke.

Muñoz X, Obach V, Hurtado B, de Frutos PG, Chamorro A, Sala N.

Thromb Haemost. 2007 Aug;98(2):406-12.

PMID:
17721624
4.

Human vitamin K-dependent GAS6: gene structure, allelic variation, and association with stroke.

Muñoz X, Sumoy L, Ramírez-Lorca R, Villar J, de Frutos PG, Sala N.

Hum Mutat. 2004 May;23(5):506-12.

PMID:
15108283
5.

ALOX5AP gene and the PDE4D gene in a central European population of stroke patients.

Lõhmussaar E, Gschwendtner A, Mueller JC, Org T, Wichmann E, Hamann G, Meitinger T, Dichgans M.

Stroke. 2005 Apr;36(4):731-6. Epub 2005 Feb 24.

6.

Phosphodiesterase 4D gene, ischemic stroke, and asymptomatic carotid atherosclerosis.

Bevan S, Porteous L, Sitzer M, Markus HS.

Stroke. 2005 May;36(5):949-53. Epub 2005 Mar 31.

7.

Genetic variants in the promoter region of the ALOX5AP gene and susceptibility of ischemic stroke.

Ji R, Jia J, Ma X, Wu J, Zhang Y, Xu L.

Cerebrovasc Dis. 2011;32(3):261-8. doi: 10.1159/000330341. Epub 2011 Aug 31.

PMID:
21893978
8.

Vitamin K-dependent proteins GAS6 and Protein S and TAM receptors in patients of systemic lupus erythematosus: correlation with common genetic variants and disease activity.

Recarte-Pelz P, Tàssies D, Espinosa G, Hurtado B, Sala N, Cervera R, Reverter JC, de Frutos PG.

Arthritis Res Ther. 2013 Mar 12;15(2):R41. doi: 10.1186/ar4199. Erratum in: Arthritis Res Ther. 2014;16(1):404.

9.

Gas6 is complexed to the soluble tyrosine kinase receptor Axl in human blood.

Ekman C, Stenhoff J, Dahlbäck B.

J Thromb Haemost. 2010 Apr;8(4):838-44. doi: 10.1111/j.1538-7836.2010.03752.x. Epub 2010 Jan 17.

PMID:
20088931
10.

Polymorphisms and noncardioembolic stroke in three case-control studies.

Luke MM, Berger K, Rowland CM, Catanese JJ, Tong CH, Ross DA, Garcia V, Kuhlenbaeumer G, Ringelstein EB, Pullinger CR, Malloy MJ, Deedwania P, Ellis SG, Kane JP, Devlin JJ, Lalouschek W, Mannhalter C.

Cerebrovasc Dis. 2012;33(1):80-5. doi: 10.1159/000333444. Epub 2011 Dec 1.

PMID:
22134093
11.

Cross-phosphorylation, signaling and proliferative functions of the Tyro3 and Axl receptors in Rat2 cells.

Brown JE, Krodel M, Pazos M, Lai C, Prieto AL.

PLoS One. 2012;7(5):e36800. doi: 10.1371/journal.pone.0036800. Epub 2012 May 14.

12.

Polymorphisms in the receptor tyrosine kinase MERTK gene are associated with multiple sclerosis susceptibility.

Ma GZ, Stankovich J; Australia and New Zealand Multiple Sclerosis Genetics Consortium (ANZgene), Kilpatrick TJ, Binder MD, Field J.

PLoS One. 2011 Feb 8;6(2):e16964. doi: 10.1371/journal.pone.0016964.

13.

Association between phosphodiesterase 4D gene and ischaemic stroke.

Staton JM, Sayer MS, Hankey GJ, Attia J, Thakkinstian A, Yi Q, Cole VJ, Baker R, Eikelboom JW.

J Neurol Neurosurg Psychiatry. 2006 Sep;77(9):1067-9.

14.

Single nucleotide polymorphisms in monocyte chemoattractant protein-1 and its receptor act synergistically to increase the risk of carotid atherosclerosis.

Nyquist PA, Winkler CA, McKenzie LM, Yanek LR, Becker LC, Becker DM.

Cerebrovasc Dis. 2009;28(2):124-30. doi: 10.1159/000223437. Epub 2009 Jun 5.

15.

Plasma concentrations of growth arrest specific protein 6 and the soluble form of its tyrosine kinase receptor Axl in patients with systemic lupus erythematosus and Behçets disease.

Gheita TA, Bassyouni IH, Bassyouni RH.

J Clin Immunol. 2012 Dec;32(6):1279-86. doi: 10.1007/s10875-012-9743-7. Epub 2012 Jul 26.

PMID:
22833165
16.

MERTK polymorphisms associated with risk of haematological disorders among Korean SLE patients.

Cheong HS, Lee SO, Choi CB, Sung YK, Shin HD, Bae SC.

Rheumatology (Oxford). 2007 Feb;46(2):209-14. Epub 2006 Jul 11.

17.

Genetic variants of TNFSF4 and risk for carotid artery disease and stroke.

Olofsson PS, Söderström LA, Jern C, Sirsjö A, Ria M, Sundler E, de Faire U, Wiklund PG, Ohrvik J, Hedin U, Paulsson-Berne G, Hamsten A, Eriksson P, Hansson GK.

J Mol Med (Berl). 2009 Apr;87(4):337-46. doi: 10.1007/s00109-008-0412-5. Epub 2008 Nov 8.

PMID:
18998106
18.

Differential TAM receptor-ligand-phospholipid interactions delimit differential TAM bioactivities.

Lew ED, Oh J, Burrola PG, Lax I, Zagórska A, Través PG, Schlessinger J, Lemke G.

Elife. 2014 Sep 29;3. doi: 10.7554/eLife.03385.

19.

Association of Phosphodiesterase 4D with ischemic stroke: a population-based case-control study.

Woo D, Kaushal R, Kissela B, Sekar P, Wolujewicz M, Pal P, Alwell K, Haverbusch M, Ewing I, Miller R, Kleindorfer D, Flaherty M, Chakraborty R, Deka R, Broderick J.

Stroke. 2006 Feb;37(2):371-6. Epub 2005 Dec 22.

20.

A gain-of-function SNP in TRPC4 cation channel protects against myocardial infarction.

Jung C, Gené GG, Tomás M, Plata C, Selent J, Pastor M, Fandos C, Senti M, Lucas G, Elosua R, Valverde MA.

Cardiovasc Res. 2011 Aug 1;91(3):465-71. doi: 10.1093/cvr/cvr083. Epub 2011 Mar 22.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk